36 related articles for article (PubMed ID: 19252364)
1. The effects of imatinib on pregnancy outcome.
Pye SM; Cortes J; Ault P; Hatfield A; Kantarjian H; Pilot R; Rosti G; Apperley JF
Blood; 2008 Jun; 111(12):5505-8. PubMed ID: 18322153
[TBL] [Abstract][Full Text] [Related]
2. Successful Planned Pregnancy through Vitrified-Warmed Embryo Transfer in a Woman with Chronic Myeloid Leukemia: Case Report and Literature Review.
Furukawa Y; Takahashi T; Suganuma R; Ohara M; Ota K; Kyozuka H; Yamaguchi A; Soeda S; Watanabe T; Komiya H; Mizunuma H; Fujimori K
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020005. PubMed ID: 31934315
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
Yadav U; Solanki SL; Yadav R
J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
[TBL] [Abstract][Full Text] [Related]
4. Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy.
Goh HG; Kim YJ; Kim DW; Kim HJ; Kim SH; Jang SE; Lee J; Kim D; Kim WS; Park SH; Kweon IY
Leuk Lymphoma; 2009 Jun; 50(6):944-51. PubMed ID: 19479613
[TBL] [Abstract][Full Text] [Related]
5. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia.
Ito K; Tominaga K; Suzuki T; Jinnai I; Bessho M
Int J Hematol; 2005 Apr; 81(3):242-5. PubMed ID: 15814335
[TBL] [Abstract][Full Text] [Related]
7. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment for patients with CML.
Goldman JM
Hematology Am Soc Hematol Educ Program; 2009; ():453-60. PubMed ID: 20008231
[TBL] [Abstract][Full Text] [Related]
9. Sustained complete cytogenetic remission in a patient with chronic myeloid leukemia after discontinuation of imatinib mesylate therapy.
Okabe S; Tauchi T; Ishii Y; Akahane D; Nunoda K; Honda S; Takaku T; Ohyashiki K
Int J Hematol; 2007 Feb; 85(2):173-4. PubMed ID: 17321998
[No Abstract] [Full Text] [Related]
10. Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia.
Tauchi T; Ohyashiki K
Int J Hematol; 2004 Jun; 79(5):434-40. PubMed ID: 15239392
[TBL] [Abstract][Full Text] [Related]
11. Optimal first-line treatment of chronic myeloid leukemia. How to use imatinib and what role for newer drugs?
Jabbour E; Cortes J; Kantarjian H
Oncology (Williston Park); 2007 May; 21(6):653-62; discussion 663-4, 667-8. PubMed ID: 17564324
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
